Type 2 Diabetes Research Study-First Time GLP1 Therapy

Now enrolling new participants…
Limited number of space…sign-up now!

Study Details

Considering GLP-1 Therapy for the First Time?
This clinical trial is evaluating a new GLP-1 medication for adults with Type 2 diabetes who have not previously used a GLP-1. The study is designed to assess the medication’s effectiveness and safety in individuals starting this type of therapy for the first time.

Location(s): Southside, FL | Doral, FL | Canton, GA

Qualifications

Age: 18 Years of age or older

Gender: All

Compensation: Paid time and travel, if qualified

Medical Exams: No cost for study-related exams

Insurance Requirements: No insurance required

Frequently Asked Questions

What is a clinical trial?
A clinical trial is a research study designed to evaluate new medical treatments, drugs, or devices to determine their safety and effectiveness.

Who can participate in a clinical trial?
Each trial has a specific eligibility criteria, such as age, medical history, and current health status. Our team will assess if you qualify.

Are clinial trial safe?
Yes. All trials are carefully regulated by health authorities and ethics committees to ensure participant safety. You will be closely monitored throughout the study.

Will I be compensated for participating?
Some studies offer compensation for time and travel expenses. Details vary by study and will be discussed during the screening process.

Do I need health insurance to participate?
No. Clinical trials do not require health insurance, and the study sponsor typically covers costs related to the research.

Can I leave a clinical trial at any time?
Yes, participation is voluntary, and you can withdraw at any time for any reason.

What happens after a clinical trial ends?
You may have a follow-up period where the research team monitors your health. In some cases, you may have continued access to the treatment.

About East Coast Institue for Research (ECIR)

Advancing Research, Centered on You

As part of the Rovia Clinical Research Site Network, ECIR delivers patient-focused clinical trials powered by national expertise and local care. With locations in Florida (Jacksonville, Lake City, St. Augustine), Georgia (Canton, Macon), and Tennessee (Jefferson City), we’re committed to advancing Type 2 diabetes research while serving the needs of the communities we call home.

Enter Your Information

(All fields are required)

Type 2 Diabetes Meta Ads; GLP-1

Name(Required)

First Name Last Name

Phone Number(Required)

Email Address(Required)

Zip / Postal Code(Required)

Date of Birth(Required)

Gender(Required)

Preferred Contact Time(Required)

Race(Required)

Select one or more options that best describe you. This information can help ensure that all populations are represented in research.

American Indian or Alaskan Native

Asian

Black or African American

Native Hawaiian or Other Pacific Islander

White or Caucasian

Are you Hispanic or Latino?(Required)

Preferred Language(Required)

Are you using a Continuous Glucose Monitor (CGM)?(Required)

Are you currently taking insulin?(Required)

Are you currently taking a once-weekly shot that helps with weight and sugar levels?(Required)

(ex. Ozempic, Wegovy, Mounjaro, etc.)

Do you have high blood sugar?(Required)

Is your HbA1c > 7%? If unknown, select "Not Sure"(Required)

Are you taking Metformin?(Required)

Name

This field is for validation purposes and should be left unchanged.